Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.
about
Review of Current International Decision-Making Processes for Newborn Screening: Lessons for AustraliaUniversal newborn screening for congenital CMV infection: what is the evidence of potential benefit?The evolution of blood-spot newborn screeningTechnical report: Ethical and policy issues in genetic testing and screening of children.Clinic-based infant screening for duchenne muscular dystrophy: a feasibility study.Obtaining consent from both parents for pediatric research: what does "reasonably available" mean?Essential genetic and genomic nursing competencies for the oncology nurse.Public support for neonatal screening for Pompe disease, a broad-phenotype condition.Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review.The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.Newborn Screening for Biliary Atresia.Expectations and values about expanded newborn screening: a public engagement study.A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document.Biobank participant support of newborn screening for disorders with variable treatment and intervention options.Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.Horizon scanning for new genomic tests.Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study.Implications of newborn screening for nurses.International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.Genetics professionals' opinions of whole-genome sequencing in the newborn period.State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.Clinical utility of genetic and genomic services: context matters.Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.Enhanced interpretation of newborn screening results without analyte cutoff values.Can a decision aid enable informed decisions in neonatal nursery recruitment for a fragile X newborn screening study?Newborn Screening in the Era of Precision Medicine.Newborn Screening: Beyond the Spot.How is genetic testing evaluated? A systematic review of the literature.Secretary's Advisory Committee on Heritable Disorders in Newborns and Children response to the President's Council on Bioethics report: the changing moral focus of newborn screening.Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis.Benefits and burdens of newborn screening: public understanding and decision-making
P2860
Q26781078-8F84EBB8-0814-4791-8038-6053857BE008Q26824199-42A143B3-0836-47C3-850E-9AABBC1F0134Q27023046-345ADBC9-ACC2-4BE3-A084-78F6E7C2D0C1Q34328987-B587C992-C451-4474-9F03-AB9E996D22CCQ34367197-00F918AE-1C26-41EB-B5A7-1DFD7AAABA70Q34522603-EDFD207F-ADFF-40B5-A164-44DEE4530BEFQ34685938-D07E24B6-729B-4E97-BB07-747022DC0731Q35956846-424D0126-9D0A-4B82-B00B-F13883202457Q36762922-008A24A9-2819-404E-B70D-E14A5DDEDD68Q37015264-48953E7D-61EE-4B98-95AE-E7A1E8437C7CQ37036993-CB1DEB1B-8A51-42FD-854D-6743C444C12EQ37333274-6C62F6C9-303E-4812-AA8A-4AEB11EBAD59Q37397665-CDDC1685-3031-4F10-B12B-C7E88D22E677Q37474855-20CF7BB0-9A93-4D81-BB79-A7904215CBFFQ37590819-1E94F407-C9DF-4AC8-8B6F-C01AEA126AB6Q37828350-D2174D77-55AD-490E-A880-A5227799E02CQ38021947-EE6ADEDA-9BC4-4CCA-BD6E-21930FA26E2AQ38078006-36E290C1-C065-4B2F-8F64-349141D6D151Q39009990-C3D5C2FA-0E25-400A-B6E2-DE346860A622Q39107529-DB06FF58-8D39-4A52-A4E4-B46C00E886C9Q40824026-AB9205F9-4177-4044-A197-A4D0DD6F5BB9Q42734175-85AB0236-25AB-4E18-AE89-905841A5F1E0Q44701578-A372437D-4C0B-49AB-A0ED-046D834CE603Q45109758-07A925BA-6121-4EDD-9F58-9128DCEBE973Q46079504-EDB8CAD5-A088-4E5B-B151-C0B5FB74CA98Q47668636-C4210C99-B978-458E-805B-60F16292A868Q50041269-59016256-A97B-4D73-8907-B0A2D5202006Q50106856-424798A1-F200-4709-B376-CA0B60517ED0Q53045347-923939BB-D998-4CCA-A026-613FB92E732AQ55037145-B1D97DFF-8B68-44A4-BB21-47061C37F77FQ57519269-FDD42FDB-6A23-41D0-AB4D-A233361F9B1A
P2860
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Committee report: Method for e ...... ning of newborns and children.
@en
Committee report: Method for e ...... ning of newborns and children.
@nl
type
label
Committee report: Method for e ...... ning of newborns and children.
@en
Committee report: Method for e ...... ning of newborns and children.
@nl
prefLabel
Committee report: Method for e ...... ning of newborns and children.
@en
Committee report: Method for e ...... ning of newborns and children.
@nl
P2093
P2860
P1433
P1476
Committee report: Method for e ...... ning of newborns and children.
@en
P2093
Advisory Committee on Heritable Disorders in Newborns and Children
Coleen Boyle
Denise Dougherty
Michael Watson
Michele Lloyd-Puryear
Nancy S Green
Ned Calonge
Piero Rinaldo
R Rodney Howell
Tracy Trotter
P2860
P2888
P304
P356
10.1097/GIM.0B013E3181D2AF04
P407
P577
2010-03-01T00:00:00Z
P6179
1036687807